Argentina:

Bladder cancer case-control study in Córdoba, Argentina

This study was based in Villa María, Córdoba. The study is defined by 3 major components for which final data analysis and report preparation is currently underway:

  1. Arsenic and bladder cancer dose-response: Bladder cancer cases and age- and sex-matched population controls from the County of Unión have been interviewed in detail including lifelong residential histories, sources of drinking water and smoking histories. Water samples have been collected from both the current residences and where possible, from previous residences. Historical data on arsenic measurements in public water supplies have also been collected. We are currently analyzing these data to assess the relationship between arsenic exposure and bladder cancer risk.  This will include an examination of the possible synergistic effect of cigarette smoking. 

 

  1. Metabolism: First-morning urine samples were collected from cases and controls. Analyses for inorganic arsenic and its methylated metabolites were conducted in the laboratory of Professor David Kalman, University of Washington. Cases and controls are being compared to see if they differ in arsenic methylation patterns. 


Molecular epidemiology: Tumor DNA has been analyzed for genetic alterations using a three-tiered approach: 

    • screening of the entire genome for gains and losses using comparative genomic hybridization (CGH);
    • specific analyses of chromosomes 9 and 17p for loss of heterozygosity using PCR- based methods; 
    • analysis of the p53 gene for mutations, using polymerase chain reaction-single-strand conformation (PCR-SSCP). 

The frequency and pattern of these genetic alterations in bladder tumors of arsenic-exposed and unexposed cases is being compared. The potential synergistic action of arsenic on genotoxic effects of cigarette smoking is currently being assessed. In addition, susceptibility differences between cases and controls is being investigated by identifying the presence or absence of the glutathione S-transferases GSTM1 and GSTT1 null genotypes in buccal cells and by comparing urinary arsenic methylation patterns. 

 

Argentina mortality study

Mortality from internal cancers was identified in areas of the Province of Córdoba, Argentina, which in the past had high levels of arsenic in drinking water. The results concerning bladder cancer have been published. The analyses concerning mortality from other cancers has also been published. Increased risks for kidney and lung cancers were found in the exposed areas.

[Return to top]

Chile:

Cross-sectional survey of arsenic-induced skin lesions in Chiu-Chiu, Northern Chile

In March 1999 a cross-sectional survey was conducted of families from two small remote villages in Region II of Chile. One village, Chiu- Chiu, was exposed to drinking water containing 800 ug/L of arsenic. The second village, Caspana, has low concentrations of arsenic in its water supply (15 ug/L). A total of 11 families participated from Chiu-Chiu and 8 from Caspana, each consisting of two adults and two children. The families were examined for skin lesions and nutritional status and the findings are currently being prepared for publication.

 

Impact of arsenic on mortality in Chile from 1950-2000

The purpose of this study is to investigate mortality in Region II of Chile, from 1950 to 2000. This region, currently with a population of close to a half million people, experienced a peak exposure to arsenic, with a population-weighted average drinking water arsenic concentration of 580 ug/L, from 1955 to 1970.  In contrast, water supplies for the rest of Chile mostly contained arsenic levels of less than 10 ug/L. Following the installation of arsenic treatment plants, arsenic concentrations were reduced, so that the average is now less than 50 ug/L.  Region II is unique in the world in the way a large population experienced a sudden increase in arsenic exposure and then a corresponding decrease in exposure more than a decade later.  This “natural experiment” affords an opportunity to investigate latencies of arsenic-associated diseases, particularly cancers.  A particular advantage of carrying out epidemiological studies in Region II is the high quality of exposure information, since everyone in this region obtained their water from municipal water supplies, for which regular monitoring has been carried out.  By contrast, in most other high arsenic areas of the world the arsenic came from many individual wells, for which historical monitoring data do not usually exist.

An investigation of mortality in Region II during 1989-1993 indicated that rates for bladder, skin, lung, and kidney cancer were increased compared to the rest of Chile. Bladder cancer mortality was markedly elevated [men, SMR = 6.0, 95% confidence interval (CI), 4.8-7.4; women, SMR = 8.2, 95% CI, 6.3-10.5] as was lung cancer mortality [men, SMR = 3.8, 95% CI, 3.5-4.1; women, SMR = 3.1, 95% CI, 2.7-3.7]. It was estimated that arsenic might account for 7% of all deaths among those aged 30 years and over. If so, the impact of arsenic on the population mortality in Region II of Chile would be greater than that reported anywhere to date from environmental exposure to a carcinogen in a major population.

The study underway is constructing a longitudinal mortality profile, by cause of death for Region II between the years 1950 and 2000. A similar mortality profile is being constructed for Region V, as an unexposed control region. As well as cancer, increased mortality might be expected from non-cancer outcomes, including cardiovascular, peripheral vascular and cerebrovascular diseases. The impact of arsenic exposure during childhood on pulmonary disease mortality in young adults, and on childhood cancer mortality, is also being assessed.

This study is taking advantage of a unique opportunity to investigate arsenic-caused mortality, including latency patterns, for one of the world's most significant environmental toxic exposures.  The study is expected to be completed in the first half of 2004.

[Return to top]

 

 India:

Dose-response study of arsenic-caused skin lesions in West Bengal, India

Our group is conducting research in collaboration with Professor D. N. Guha Mazumder and  his research team at the Institute of Post Graduate Education and Research (IPGMER) in Calcutta, India. We analyzed data from a large cross-sectional survey of about 7000 people in an arsenic-exposed region in West Bengal. The dose-response analysis linking cases of  skin keratoses and hyperpigmentation to arsenic water levels has been recently published.

We recently completed data collection for a case-control study nested in the same survey, which focuses on participants with skin lesions who had drinking water arsenic levels of less than 500 ug/L. Detailed interviews concerning water sources and fluid consumption, diet, smoking and medical history were completed for over 400 participants. Water samples were obtained from all known drinking water sources. Each participant received a physical examination for skin lesions and other signs, and portable spirometry was conducted. Blood and urine samples were also collected to assess micronutrient status and arsenic metabolism. Data from this study are currently being analyzed. 

Studies on the effect of arsenic on respiratory, reproduction and child development in West Bengal

In addition to the dose-response study, we recently launched two new studies in West Bengal

The first new study was generated by our preliminary findings from a cross-sectional study in which we examined the respiratory effects associated with ingesting arsenic (see Guha Mazumder et al., 2001). The prevalence of cough, chest sounds, and shortness of breath were dramatically elevated among individuals with skin lesions. These findings raised the possibility that respiratory effects are largely present only in people with skin lesions. We, therefore, set out to confirm these results in a more focused study. Participants will include 135 individuals who have arsenic-induced skin lesions, and were exposed to high arsenic levels (>500 ug/L) through their primary water sources. The comparison group will include individuals with normal skin, but consumed water with low arsenic levels (<50 ug/L). Data collection for this detailed study commenced April 2001. 

The second investigation examines the potential effects of arsenic on reproduction and child development.  Extensive studies have been conducted concerning various effects of ingestion of inorganic arsenic in drinking water, and health effects in adults. So far little has been done to investigate reproductive effects in pregnancy and effects on child development. The goal of the proposed study is to investigate pregnancy outcomes in a retrospective study of 100 women already known to have been drinking water containing more than 500 ug/L of arsenic. These women will be compared to 100 women whose drinking water contained less than 50 ug/L of arsenic. Live births, birth spacing, spontaneous abortion, and stillbirths will be compared between exposed and unexposed mothers. Children aged 5-15 will receive a medical examination, and their cognitive abilities and learning achievements will be evaluated. Detailed nutritional assessment of each family will be undertaken to search for potential effect modifying role of nutrition on arsenic effects. Urine samples will be collected from women and their children to identify metabolic susceptibility. Interviews for this study commenced April 2001.

[Return to top]

United States:

Bladder cancer case-control study in Nevada and California

The California/Nevada bladder cancer study is a population-based, case-control study that will examine the hypothesis that bladder cancer is caused by ingestion of arsenic in drinking water at relatively low concentrations. The study population includes residents of Kings County in California, and six counties in Nevada (Churchill, Mineral, Lyon, Douglas, Storey and Carson). These counties were chosen because they include water supplies which had close to 100 ug/L of arsenic, the highest level of arsenic found in major water supplies in the U.S. Other water supplies in the study region contain less than 10 ug/L and thus provide a marked contrast in exposure. Two hundred bladder cancer cases diagnosed between 1994 and 2000 are being identified from the California and Nevada Tumor Registries. Random digit dial (RDD) is being used to identify 400 controls who will be frequency matched to cases by sex and 5-year age groups. Structured personal telephone interviews are being administered to obtain lifetime residential history and detailed information on current and past water consumption patterns. Information is also being obtained regarding cigarette smoking (which may be synergistic with arsenic in causing bladder cancer), chlorination of drinking water, diet, and occupational history. Although the effect of arsenic at 100 ug/L is uncertain, this study has over 90% statistical power to detect a relative risk of 2.0, which was predicted by linear extrapolation of data from studies in Taiwan.

California Arsenic Methylation Study

Increasing evidence suggests that arsenic in drinking water is an important cause of human cancer, including bladder cancer. Methylation of inorganic arsenic after ingestion reduces its toxicity, but little is known about the impact of diet on arsenic methylation, nor about variation between people in the fraction of inorganic arsenic methylated in the body. The specific aims of this project are: 1.To assess the influence of diet on the extent of methylation of inorganic arsenic. 2.To quantify intra-individual and inter-individual variability in arsenic methylation. 3.To compare arsenic methylation patterns between bladder cancer patients and controls. The study population involves a subset of the bladder cancer cases and frequency matched controls who are being selected as part of an on-going case-control study on the cancer risks associated with moderate levels of arsenic in drinking water. Study participants are residents of Kings County, California where a large proportion of the current water supply contains arsenic at concentrations close to 50 ug/l. Cases are being ascertained from the Cancer Registry of Central California, and controls are randomly selected from the general population. Detailed information encompassing residential history, water sources, fluid consumption, typical diet, plus lifestyle and demographic factors including smoking, is being obtained using validate questionnaire and telephone interview methods. The study takes advantage of the opportunity to study arsenic methylation in this study population. First morning urine samples will be obtained from 50 of the bladder cancer patients and 100 of the controlprogram, with a new focus on malignant and non-malignant pulmonary disease resulting from ingestion of inorganic arsenic in drinking water. The reason for this new focus is the fact that risk estimation based on findings from three countries, including our own studies in Argentina and Chile, show that lung cancer contributes more to increased cancer mortality due to arsenic ingestion than all other arsenic-caused cancers combined, including bladder, kidney and skin cancer. Improving population cancer risk estimation is therefore critically dependent on a better understanding of arsenic-induced lung cancer. In addition to causing lung cancer, ingested arsenic may also cause non-malignant respiratory effects as evidenced by our studies in West Bengal, India, and our finding of increased mortality from chronic respiratory disease in persons exposed to arsenic as children in Chile. We therefore plan to investigate both malignant and non-malignant pulmonary disease originating from ingestion of inorganic arsenic in drinking water. We will conduct a lung cancer case-control study in Córdoba, Argentina with dose-response examination using individual exposure data based on measured water arsenic concentrations. Individual susceptibility will be assessed by arsenic methylation patterns in urine and glutathione transferase and MTHFR genotypes determined from buccal cell DNA. The study will include an examination of genetic alterations in tumors including p53 mutations, DNA methylation, and comparative genomic hybridization, and will investigate synergy with cigarette smoking. The lung cancer DNA study will be supplemented with DNA of tumors from a highly exposed population in Chile, where we will also conduct a case-control study of chronic respiratory disease mortality focusing on effects of arsenic exposure during childhood. Chronic respiratory disease, arsenic-caused skin lesions, and nutritional susceptibility will be the focus of a study in West Bengal, India. Arsenic effects in children will be part of this study, plus a study of children with skin lesions in Bangladesh and further study of two children with skin lesions in Chile. Our overall goal is to investigate both malignant and non-malignant pulmonary disease effects of inorganic arsenic to enable better assessment of population risks, including the health effects resulting from childhood exposures.

[Return to top]




University of California, Berkeley ~ School of Public Health ~ 50 University Hall MC7360 ~ Berkeley, CA 94720-7360

Telephone: 510/843-1736
E-mail: asrg@berkeley.edu